Also known as Acetyl Hexapeptide-8 · Acetyl Hexapeptide-3 · Ac-EEMQRR-NH2
A topical "neurocosmetic" hexapeptide that mimics SNAP-25 to soften expression wrinkles — often called topical Botox.
Research refreshed
Argireline (acetyl hexapeptide-8) is a synthetic hexapeptide widely used in anti-aging cosmetics. It mimics the N-terminal end of SNAP-25, a protein in the SNARE complex that nerve endings use to release the signals that make facial muscles contract. By competing in that complex, Argireline is proposed to reduce the muscle contractions behind expression lines — the reason it is marketed as a topical, needle-free alternative to botulinum toxin.
Argireline was the peptide that launched the "neurocosmetic" category — topical ingredients that borrow the logic of botulinum toxin without the toxin. Its six-residue, N-acetylated sequence mimics the very end of SNAP-25, one of the SNARE proteins a nerve terminal uses to dock and release its signaling vesicles. By slotting into that machinery, Argireline is proposed to blunt the release that tells a facial muscle to contract, so repeated expressions crease the skin less.
In practice it is a cosmetic-formulation ingredient, applied to the skin in serums and creams rather than injected, and its measured effects are modest and surface-level compared with injected botulinum toxin. It sits in this catalog alongside the other skin peptides — the copper peptides and matrixyl — as a reference entry: a well-defined, widely sold compound whose mechanism is genuinely interesting even where the marketing outruns the evidence. It is a cosmetic ingredient, not an FDA-approved drug.
Mimics the N-terminus of SNAP-25, competitively interfering with SNARE-complex assembly and reducing neurotransmitter release at the neuromuscular junction — dampening the muscle contractions that form expression wrinkles.
Behind every vial of Argireline is the same exacting pipeline every research peptide runs — but the chemistry plays out differently for this molecule. Here is how Argireline, specifically, is brought into being.
On paper, Argireline is C35H62N14O11S — about 887 daltons of precisely arranged atoms. Before a single bond is made, the target sequence, salt form, and purity threshold are written down as the contract the finished material must meet.
Argireline is built one protected residue at a time by solid-phase synthesis, each cycle a deprotection, a coupling, and a wash. Its C-terminus is amidated rather than left as a free acid — a defined modification the synthesis has to deliver, not an afterthought.
The crude mixture — Argireline plus its deletions and side products — is then separated on preparative HPLC, and where the cut is taken decides the difference between a genuinely pure peptide and a barely-passable one.
A real batch of Argireline proves itself: identity confirmed by mass spectrometry against its ~887 Da, purity read directly off an analytical HPLC trace, water and counterion content measured. That batch-specific certificate of analysis is the only honest way to know what is actually in a vial of Argireline — and a short, cold, accountable chain of custody is how that purity survives the trip to your bench.
Argireline (acetyl hexapeptide-8) is a short N-acetylated, C-terminally amidated hexapeptide made by routine solid-phase synthesis. The two end modifications are the defining steps; the sequence is otherwise straightforward, and the acetate counterion and residual solvents dominate cosmetic-grade QC.
Don't judge a vial by its cake. A fluffy, good-looking lyophilized powder reflects bulking agents and freeze-drying parameters — not purity. Insist on a batch-specific certificate of analysis.
Recent clinical trials and publications mentioning Argireline, pulled automatically from ClinicalTrials.gov and PubMed and refreshed daily. Listings are unfiltered search results, not curated endorsements.
Argireline (acetyl hexapeptide-8) is a synthetic hexapeptide used in anti-aging cosmetics that mimics SNAP-25 to reduce the muscle contractions behind expression wrinkles.
It borrows the same SNARE / SNAP-25 logic as botulinum toxin, but it is applied topically and its effects are modest and superficial — not equivalent to injected Botox.
Argireline targets muscle-contraction signaling (expression lines); matrixyl (a palmitoyl peptide) signals fibroblasts to make more collagen. They address different aspects of skin aging.
It is a cosmetic ingredient, not an FDA-approved drug. This page is a research and educational reference.
Endogenous copper-binding tripeptide widely studied in skin and hair biology.
ViewCopper-binding tripeptide (Ala-His-Lys) studied for hair-follicle stimulation and dermal repair.
ViewPalmitoylated matrikine peptide that signals fibroblasts to synthesize collagen — contains no copper.
ViewDosing protocols, mechanism, comparisons, and the latest trials — citation-backed answers grounded in PubMed, PubChem, and ClinicalTrials.gov.